Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 46.50
Bid: 46.00
Ask: 47.00
Change: -0.25 (-0.53%)
Spread: 1.00 (2.174%)
Open: 45.75
High: 46.50
Low: 45.50
Prev. Close: 46.75
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Omega Wins First Order For Antibody Test

Tue, 09th Jun 2020 11:14

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Tuesday and not separately reported by Alliance News:

----------

Avacta Group PLC - Wetherby-based Affimer biotherapeutics developer - Bead-assisted mass spectrometry diagnostics test for Covid-19 infection being developed with partner Adeptrix has reached prototype stage, and can detect the coronavirus spike protein in model sample in the range appropriate for a clinical diagnostic test. Next development step is evaluate and optimise assay before moving to manufacturing and clinical validation.

----------

Omega Diagnostics PLC - Alva-based medical diagnostics - Expects Ebitda for year ended March between GBP850,000 to GBP900,000, ahead of market expectations and up from GBP199,668. Signs long-term supply agreement with Mologic Ltd, for the supply of raw materials for Omega to manufacture its CE-Marked ELISA antibody test. Also signs material transfer agreement with Mologic. Announces first order for test to Senegal worth GBP100,000.

----------

Braveheart Investment Group PLC - Barnsley-based investment holding firm - Paraytec announces that the required affinity macromolecule an aptamer that bonds to the SPIKE glycoprotein on the surface of the Covid-19 virus has been synthesised and supplied to Paraytec from the University of Sheffield. Paraytec expects to complete the production of SPIKE protein in cell factories, and modification of test surface with aptamer in one month.

----------

Ilika PLC - Romsey-based solid-state battery firm - Trading for year ended April 30 in line with expectations. Revenue expected to be GBP2.8 million, up from GBP2.6 million, and narrowed Lbitda of GBP2.1 million from GBP2.2 million. Romsey headquarters remains open throughout lockdown period, while data analytics and business discussions have continued remotely. Expects Stereax pilot line at University of Southampton to reopen shortly.

----------

Sosandar PLC - Cheshire-based women's clothing retail - Reports strong growth in first two months of financial year ending March 31, 2021 despite challenges. Order growth for two months to May 31 up 44% year-on-year, revenue grows by 62%. Increased traffic up 98%, but lower levels of conversion. Marketing expenses reduced, 60% of workforce furloughed, board remuneration reduced. For recently ended year, expects revenue to be at least GBP9 million, up from GBP4.4 million.

----------

SigmaRoc PLC - London-based construction materials - For five months ended May, reports revenue of GBP42 million. In April and May, restriction in Channel Islands lifted allowing Ronez operations to resume more normal trading. In UK, PPG and South Wales platforms scaled up towards full production at end of April and into May. Belgium operations remained active, despite lower activity level.

----------

S&U PLC - Birmingham-based motor finance & property bridging lender - In Advantage Finance, sales for financial year-to-date down to 15% of normal levels due to plummeting car usage, closure of car dealers and ceasing of deliveries, But transactions have now recovered to around 40% of normal. In Aspen Bridging, transaction numbers under a quarter of those budgeted in the year. Improvement seen in both segments.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
19 Jun 2023 10:16

Avacta denies press speculation over potential fundraising

(Sharecast News) - Oncology drug developer Avacta Group responded to recent market speculation over a potential fundraising initiative on Monday.

Read more
19 Jun 2023 09:09

LONDON MARKET OPEN: Stocks falter amid weaker outlook for China

(Alliance News) - Stock prices in London opened lower on Monday, ahead of more interest rate decisions, and amid fears for China's slowing economic recovery.

Read more
19 Jun 2023 07:53

LONDON BRIEFING: Severn Trent deal sized up by CMA; Coca-Cola HBC buys

(Alliance News) - Stocks in London are called lower on Monday, ahead of more central bank decisions, while a meeting between US Secretary of State Antony Blinken and his Chinese counterpart put relations between the two nations back under the spotlight.

Read more
5 Jun 2023 12:28

Avacta triggers second milestone payment in AffyXell venture

(Sharecast News) - Life science company Avacta Group announced on Monday that a second milestone equity payment had been triggered, resulting in an increased shareholding for Avacta in AffyXell Therapeutics.

Read more
5 Jun 2023 12:06

Avacta sees shares rise on new equity payment for South Korea venture

(Alliance News) - Avacta Group PLC on Monday celebrated "rapid" progress on its joint venture in South Korea, following a second equity payment.

Read more
1 Jun 2023 14:53

Avacta buys Belgium-based Coris Bioconcept for £7.4m

(Sharecast News) - Life science company Avacta Group announced the acquisition of Coris Bioconcept for initial cash consideration of £7.4m on Thursday.

Read more
1 Jun 2023 10:24

Avacta enhances rapid test portfolio with GBP7.4 million Coris buy

(Alliance News) - Avacta Group PLC on Thursday said that it has bought Coris Bioconcept SRL, adding a range of professional-use rapid tests to its product portfolio.

Read more
27 Apr 2023 14:34

TRADING UPDATES: Volex wins contract; Engage XR revenue jumps

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
27 Apr 2023 12:11

Avacta doses first patient in US tumour treatment trial

(Sharecast News) - Oncology and diagnostics developer Avacta announced the dosing of the first patient in the United States under its investigational new drug (IND) application on Thursday - a milestone for its first therapeutic product 'AVA6000', based on its proprietary 'preCISION' technology.

Read more
25 Apr 2023 14:39

EARNINGS SUMMARY: hVIVO sees 30% revenue growth; Next 15 lifts payout

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
25 Apr 2023 13:51

Revenue rises, adjusted EBITDA loss improves for Avacta

(Sharecast News) - Oncology-focussed drugs and diagnostics developer Avacta reported full-year revenue of £9.7m in its preliminary results on Tuesday, up from £2.9m year-on-year.

Read more
18 Apr 2023 15:47

UK earnings, trading statements calendar - next 7 days

Wednesday 19 April 
Antofagasta PLCTrading Statement
discoverIE Group PLCTrading Statement
Distribution Finance Capital Holdings PLCFull Year Results
Hunting PLCTrading Statement
Just Eat Takeaway.com NVTrading Statement
Kainos Group PLCTrading Statement
Liontrust Asset Management PLCTrading Statement
M Winkworth PLCFull Year Results
Network International Holdings PLCTrading Statement
Thursday 20 April 
AJ Bell PLCTrading Statement
Arix Bioscience PLCFull Year Results
Centamin PLCTrading Statement
Deliveroo PLCTrading Statement
Dianomi PLCFull Year Results
Dunelm Group PLCQ3 Results
Foxtons Group PLCTrading Statement
GB Group PLCTrading Statement
Hochschild Mining PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Oxford BioMedica PLCFull Year Results
PensionBee Group PLCTrading Statement
Rentokil Initial PLCTrading Statement
Rio Tinto PLCTrading Statement
Senior PLCTrading Statement
Segro PLCTrading Statement
WH Smith PLCHalf Year Results
Friday 21 April 
Angle PLCFull Year Results
BHP Group LtdTrading Statement
Lookers PLCFull Year Results
Monday 24 April 
Brighton Pier Group PLCFull Year Results
CentralNic Group PLCTrading Statement
Checkit PLCFull Year Results
Egdon Resources PLCHalf Year Results
Keystone Law Group PLCFull Year Results
Lok'n Store Group PLCHalf Year Results
Novacyt SAFull Year Results
Tuesday 25 April 
AB Dynamics PLCHalf Year Results
Anglo American PLCTrading Statement
Associated British Foods PLCHalf Year Results
Avacta Group PLCFull Year Results
Banco Santander SAQ1 Results
Card Factory PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Corero Network Security PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
IWG PLCTrading Statement
Jadestone Energy PLCFull Year Results
Next Fifteen Communications Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Petrofac LtdFull Year Results
Quilter PLCTrading Statement
Resolute Mining LtdTrading Statement
RWS Holdings PLCTrading Statement
Travis Perkins PLCTrading Statement
WAG Payment Solutions PLCTrading Statement
Whitbread PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
17 Apr 2023 09:43

Avacta presents pre-clinical data for anti-cancer candidate

(Sharecast News) - Life science company Avacta Group announced the presentation of pre-clinical data for its novel 'preCISION' proteasome inhibitor AVA3996 on Monday.

Read more
6 Apr 2023 12:14

Avacta opens first two clinical investigator sites in US for AVA6000

(Alliance News) - Avacta Group PLC on Thursday said it opened its first two clinical investigator sites for the phase 1 clinical trial of AVA6000 on Wednesday, under it US investigational new drug application.

Read more
6 Apr 2023 10:09

Avacta opens first US clinical investigator sites

(Sharecast News) - Life sciences company Avacta has opened its first two clinical investigator sites in the US for a Phase 1 clinical study on its AVA6000 candidate.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.